DIRECTOR, NATIONAL ACCOUNTS 3 of 3

ROLE SUMMARY

Reporting to the Executive Director, Payer Access, the Director of National Accounts is responsible for facilitating the introduction, education, and access /reimbursement of ZTI products within national/regional payers and PBMs across the Commercial, Medicare, and Medicaid books of business, as well as the Veteran’s Administration (VA), Dept. of Defense and other federal/state agencies or integrated delivery network accounts, as assigned. Directors will be responsible for the development and execution of strategic account plans. Subsequent implementation of the strategy and tactics will be driven through alignment of the strategy with defining critical success factors, key performance indicators, and the supporting tactics for our products. This individual will need to work closely with patient services, distribution, sales, marketing, MSLs and commercial operations on a routine basis to ensure alignment in a fast‑paced matrix environment.

RESPONSIBILITIES

Create and execute a business strategy and execution plan for assigned commercial/federal/state government payer markets with an objective to minimize access barriers through streamlined and transparent coverage resulting in smooth patient access to therapy Drive education in coordination with commercial leadership and other Value & Access team members regarding commercial/federal/state marketplace activities and make recommendations for their pull through success in this marketplace to maximize appropriate use Execute and support any necessary commercial/government contracts as necessary to optimize reimbursement /product access. Responsible for staying current with the evolution of trends and policies related to the commercial/federal/state government access markets Create and update business strategies and plans as needed. Facilitate communication about this segment across all relevant stakeholders Establish critical relationships with a variety of stakeholders within this segment Establish Zydus Therapeutics as a strategic partner for commercial, federal and state customers. Reactively respond to any identified coverage issues and market access challenges within a given payer segment Lead and demonstrate the ability to expand or build long‑term executive level account relationships with targeted accounts Collaborate with brand and medical teams to continually improve relationships Attend key trade meetings (ex. PCMA, AMCP), POA’s and sales meetings Develop internal triage process in collaboration with field leadership around coverage concerns including denials or appeals and a plan to remediate

QUALIFICATIONS

Bachelor's Degree, with an advanced degree preferred. 10+ years of proven pharmaceutical/biotech industry experience in Market Access or account management (preferably with rare or specialty pharmaceuticals). Broad and deep relationship customer‑facing experience with one or more national accounts (ex. CVS, ESI, UHG) Outstanding customer relationships, interpersonal, and verbal/written communication skills, with the established ability to effectively work with diverse audiences and influence cross‑functionally Proven negotiation skills and problem‑solving capabilities. An established track record of success securing optimal formulary coverage at assigned accounts. Rare/specialty oral launch experience (pharmacy benefit) strongly preferred. Strong analytical skills with the proven ability to effectively analyze data to determine trends and inform strategy. Deep insight within Medicare, Medicaid, and other government channels is required. Superior collaboration skills, with the ability to prioritize effectively, addressing short‑term needs while maintaining a focus on long‑term strategies. Must have an in-depth knowledge of current trends in commercial/federal/state marketplace as well have an understanding of current healthcare regulations, contracting and reimbursement Proven ability to work effectively across multi‑disciplinary teams

TRAVEL REQUIREMENTS

The position will require domestic travel (up to 40%), including nights and weekends on occasion #J-18808-Ljbffr Zydus Therapeutics Inc.